Navigation Links
Nasseo Wins CONNECT Life Sciences Capital Competition and Joins CONNECT Portfolio
Date:3/12/2013

San Diego, CA (PRWEB) March 12, 2013

Nasseo, Inc. is honored to announce that it has won CONNECT’s Life Sciences Capital Competition and has subsequently earned the distinction of becoming a CONNECT Portfolio Company. Competing against a large pool of highly qualified California-based life science companies, Nasseo was selected by a panel of distinguished judges for its “radical innovation in the Southern California start-up scene”. Pursuant to its victory, the Company has been invited to present its proprietary implant surface modification technology for dental and orthopedic applications to a group of venture capital investors at the March 14th Capital Roadshow in Palo Alto, California at the offices of Morrison & Foerster.

Nasseo’s first product, the TiArray™ Dental Implant is an easy-to-use, cost-effective dental implant system for patients with poor circulatory issues (e.g. diabetics, smokers) as well as for the general population. Nasseo’s technology addresses the ongoing problem of dental implant failures, which account for $1.2B annually in patient healthcare costs in the United States.

Nasseo’s selection earlier this year to CONNECT Springboard, a distinguished business mentorship and networking program, was a key milestone for the company. The CONNECT Springboard program introduced Nasseo to serial life sciences entrepreneur Bill Gerhart for executive mentorship. Mr. Gerhart was previously Founder, President & CEO of Elevation Pharmaceuticals, which developed new aerosol therapies for underserved respiratory patient populations, and which he sold in 2012 to Sunovion Pharmaceuticals for up to $430 million. After undergoing a rigorous screening and completing the mentoring process with Gerhart, Nasseo was further vetted to present in the CONNECT Life Sciences Capital Competition.

Dr. Garrett Cale Smith, PhD, CEO of Nasseo says, “Bill Gerhart has successfully led several life sciences companies through the growth stages that Nasseo is now experiencing. His insight on how to strategically position the company for investment was instrumental. We are grateful for his continued support.”

Nasseo’s TiArray™ dental implant product and its proprietary technology have drawn significant interest from the scientific and investment communities. Last year, the company presented at World’s Best Technology (WBT) Innovation Marketplace 2012, and also received the 1st place prize at the 6th Annual UC San Diego Entrepreneur Challenge Business Plan Competition, where it was the first startup to ever win both the UCSD Entrepreneur Challenge Executive Summary and Business Plan Competitions in the same year. Nasseo most recently announced that it had been selected into the BioInspire™ medical technology incubator, and had subsequently closed its $520K seed round of funding.

Dr. Garrett Cale Smith, PhD, CEO of Nasseo, says, “CONNECT has offered us a number of dynamic opportunities to grow our company. We look forward to the opportunity to introduce the Nasseo TiArray™ dental implant system to a new audience of VCs at the March 14th Capital Roadshow.”

Additionally, CONNECT has invited Nasseo to be one of eight emerging companies across all disciplines to present at its annual Rock Stars of Innovation Summit in San Diego on April 12, a premier showcase at the Hard Rock Hotel to be attended by over 250 technology and investment leaders. The company is moving forward with plans to raise a $3M+ Series A investment round in mid 2013 to catalyze production and sales.

About Nasseo, Inc.
Nasseo, Inc. is a medical device company using state of the art surface modification technology to provide patients and clinicians with the next generation of dental and orthopedic implants. The company is based in San Diego, CA. For more information, please visit us at http://www.nasseo.com or contact us at info@nasseo.com.

Read the full story at http://www.prweb.com/releases/2013/3/prweb10520898.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Nasseo, Inc. Joins BioInspire™ Medical Technology Incubator, Closes Seed Funding Round
2. Compressus Drives Programmable Workflow And Unprecedented Flexibility With Introduction of MEDxConnect™ v4.0
3. Life Technologies Ion Personal Genome Machine Receives San Diegos CONNECT Most Innovative New Product Award
4. Breaking Study: ICU Medicals Tego® Needlefree Connector Proves More Cost Effective Than Traditional Central Venous Catheter Locks
5. ConnectBiotech.org Launched, a Unique Life Science Business Networking Site
6. Excel Life Sciences Joins DATATRAKs Connect Partner Program
7. Blue Brain Project accurately predicts connections between neurons
8. Low-resistance connections facilitate multi-walled carbon nanotubes for interconnects
9. Caris Sponsors CancerCare Connect Education Workshop on Molecular Profiling in the Treatment of Breast Cancer
10. CureLauncher is a New Website That Connects Patients to Trials Across the U.S.
11. Aspiring Photonics Entrepreneurs to Vie for Prizes, Connections in SPIE Startup Challenge
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/18/2019)... ... ... Tune in to CNBC on Saturday, December 28th at 11:00aET to watch a ... on this program. , With a look at Avatar Partners , Advancements will ... the efficiency, safety and effectiveness of equipment, systems, and processes for the Warfighter, First ...
(Date:12/6/2019)... (PRWEB) , ... December 06, ... ... manufacturer Vascular Medcure, Inc. has received FDA 510(k) clearance for its latest ... company’s early clinical data suggests the CAPERE® offers great benefits for first-in-line ...
(Date:12/4/2019)... ... 03, 2019 , ... Absolute Antibody Ltd. , an ... the Recombinant Antibody Network (RAN), a consortium of three expert centers at the ... common goal to generate recombinant antibodies at a proteome-wide scale. Under the new ...
(Date:12/4/2019)... ... , ... A new study released today in STEM CELLS outlines how fat ... tissue) buildup – also improves the range of motion of the affected limb. The ... , The tumor-destroying capabilities of radiation therapy can be a life saver for ...
Breaking Biology Technology:
(Date:12/30/2019)... ... December 30, 2019 , ... It’s been quite a ... seen its highest sales in 2019, having hosted a multitude of team-building events and ... visited the company’s La Jolla-based venue, and the company has worked hard to accommodate ...
(Date:12/18/2019)... ... December 17, 2019 , ... PM360, a ... and diagnostics industries, has named Pharmafusion LLC as one of the most innovative ... company and its founder/CEO Jonathan Retano. Earlier in the year, Pharmafusion was featured ...
(Date:12/4/2019)... ... December 03, 2019 , ... Genedata, ... Agenus , a clinical-stage immuno-oncology company developing therapies to fight cancer, has ... platform. Agenus will use the platform to support immunotherapy and vaccine pipeline programs ...
Breaking Biology News(10 mins):